Compared to previous findings that LXRβ activation reduces microglial activation [28], our study further reveals the differences between LXRβ agonists and antagonists in regulating glial differentiation, providing a new perspective for understanding the pathogenesis of FCD. Here, NR1H2 is linked to fleck corneal dystrophy.